Please use this identifier to cite or link to this item: https://ir.swu.ac.th/jspui/handle/123456789/13612
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSaiyudthong S.
dc.contributor.authorPongmayteegul S.
dc.contributor.authorMarsden C.A.
dc.contributor.authorPhansuwan-Pujito P.
dc.date.accessioned2021-04-05T03:25:03Z-
dc.date.available2021-04-05T03:25:03Z-
dc.date.issued2015
dc.identifier.issn14786419
dc.identifier.other2-s2.0-84942248560
dc.identifier.urihttps://ir.swu.ac.th/jspui/handle/123456789/13612-
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-84942248560&doi=10.1080%2f14786419.2014.992342&partnerID=40&md5=d479edf07b67f41f1706efd829e35f03
dc.description.abstractVetiver essential oil (VEO) has been used in aromatherapy for relaxation. This study aimed to investigate the effects of VEO on an anxiety-related behavioural model (the elevated plus-maze, EPM) and immediate-early gene c-fos in amygdala, known to be involved in anxiety. Male Wistar rats were administered diazepam (1 mg/kg i.p.) for 30 min or inhalated with VEO (1%, 2.5% or 5% w/w) for 7 min prior to exposure to the EPM. Then, the effects of 2.5% VEO, the anxiolytic dose, on c-fos expression in amygdala were investigated. The rats given either 2.5% VEO or diazepam exhibited an anxiolytic-like profile in the EPM. VEO and diazepam significantly increased c-fos expression in the lateral division of the central amygdaloid nucleus (CeL). Therefore, the anxiolytic properties of VEO might be associated with altering neuronal activation in CeL. However, future studies are needed to investigate the precise mechanism of action of VEO. © 2015 Taylor & Francis.
dc.subjectanxiolytic agent
dc.subjectdiazepam
dc.subjectessential oil
dc.subjectprotein c fos
dc.subjectunclassified drug
dc.subjectVetiver essential oil
dc.subjectanxiolytic agent
dc.subjectdiazepam
dc.subjectessential oil
dc.subjectprotein c fos
dc.subjectamygdaloid nucleus
dc.subjectanimal experiment
dc.subjectanxiety
dc.subjectArticle
dc.subjectcentral nucleus (amygdala)
dc.subjectcontrolled study
dc.subjectelevated plus maze test
dc.subjectgene expression
dc.subjectimmediate early gene
dc.subjectmale
dc.subjectnonhuman
dc.subjectoncogene c fos
dc.subjectrat
dc.subjectVetiveria
dc.subjectanimal
dc.subjectanxiety
dc.subjectaromatherapy
dc.subjectchemistry
dc.subjectdrug effects
dc.subjectdrug therapy
dc.subjectinhalational drug administration
dc.subjectmental stress
dc.subjectmetabolism
dc.subjectVetiveria
dc.subjectWistar rat
dc.subjectAdministration, Inhalation
dc.subjectAmygdala
dc.subjectAnimals
dc.subjectAnti-Anxiety Agents
dc.subjectAnxiety
dc.subjectAromatherapy
dc.subjectDiazepam
dc.subjectMale
dc.subjectOils, Volatile
dc.subjectProto-Oncogene Proteins c-fos
dc.subjectRats, Wistar
dc.subjectStress, Psychological
dc.subjectVetiveria
dc.titleAnxiety-like behaviour and c-fos expression in rats that inhaled vetiver essential oil
dc.typeArticle
dc.rights.holderScopus
dc.identifier.bibliograpycitationNatural Product Research. Vol 29, No.22 (2015), p.2141-2144
dc.identifier.doi10.1080/14786419.2014.992342
Appears in Collections:Scopus 1983-2021

Files in This Item:
There are no files associated with this item.


Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.